Skip to main content
SpringerLink
Log in

Alte und Neue Risikofaktoren unter besonderer Berücksichtigung des Fibrinogens

  • Chapter
20 Jahre Kardiologie 1973–1993

  • 15 Accesses

Zusammenfassung

Der Prävention kommt in der Kardiologie ein besonders hoher Stellenwert zu (1). Demzufolge ist zu erwarten, daß durch Maßnahmen, die den arteriosklerotischen Grundprozeß und seine thrombotischen Komplikationen günstig beeinflussen, die kardiovaskuläre Mortalität und Morbidität entscheidend reduziert werden. Eine wesentliche Voraussetzung ist allerdings eine effektive Kontrolle sämtlicher kardiovaskulärer Risikofaktoren (2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Gleichmann U, Mannebach H, Gleichmann S (1984): Prävention der KHK, praktische Gesichtspunkte. Z. Kardiol 73 (Suppl 2): 143–148 (1984)

    PubMed  Google Scholar 

  2. Gleichmann U, Mannebach H, Gleichmann S (1991): Kontrolle der Risikofaktoren bei dokumentierter koronarer Herzkrankheit (KHK): Ist eine Regression möglich? In: Herausforderung Atherosklerose in der 90ern; Herausgeber U. Gleichmann, H. Mannebach, S. Gleichmann, K. Held; 34–43, Steinkopff-Verlag Darmstadt

    Google Scholar 

  3. Ernst E, Resch K-L(1993): Fibrinogen as a Cardiovascular Risk Factor: A Meta-Analysis and Review of the Literature. Ann. Intern. Med. 118: 956–963

    PubMed  CAS  Google Scholar 

  4. Assmann G, Schulte H (1993): Results and Conclusions of the Prospective Cardiovascular Münster (PROCAM) Study, 35; in: G.Assmann (Ed): Lipid Metabolism Disorders and Coronary Heart Disease; MMV Medizin Verlag, München

    Google Scholar 

  5. Yarnell IWG, Baker IA, Sweetnam PM, Bainton D, O’Brien JR, Whitehead PJ, Elwood PC ( 1991 ): Fibrinogen, Viscosity, and White Blood Cell Count are Major Risk Factors for Ischemic Heart (1991)

    Google Scholar 

  6. Koenig W, Ernst E (1992): The possible role of hemorheology in atherothrombogenesis. Atherosclerosis 94: 93–107

    Article  PubMed  CAS  Google Scholar 

  7. Lee MH, Mankowsk M, Mc Donagh J(1992): Plasminogen Binding Impairment to Clots Formed at High Fibrinogen Concentration: High Level of Fibrinogen as a Risk Factor for Thrombosis. Circulation (Suppl) 86: I–735

    Google Scholar 

  8. Kienast J, Leppelmann M, van de Loo J (1991): Hämostasefaktoren und koronare Herzkrankheit. Fibrinogen, Fraktor VII und Plasminogenaktivator-Inhibitor. Hämostaseologie 11: 172–88

    CAS  Google Scholar 

  9. Leschke M, Höffken H, Vogt,M. Motz W, Strauer BE (1988): Hyperfibrinogenämie und pathologische Plasmaviskosität. Dtsch. Med. Wschr. 113: 1175–1181

    Article  PubMed  CAS  Google Scholar 

  10. ECAT Angina Pectoris Study Group (1993): ECAT angina pectoris Study: baseline associations of hemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography, Eur. Heart J. 14: 8–17

    Article  Google Scholar 

  11. Baller D, Diekmann J, Miche E, Gleichmann U (1993): Simultaneous measurements of plasminogen activator inhibitor activity, viscosity and fibrinogen in relation to the coronary score, Clin. Hemorheol. 13 (3), 287

    Google Scholar 

  12. Baller D, Miche E, Prohaska W, Weiße G, Hurtardo R, Faßbender D, Mannebach H, Seggewiß H, Ohlmeier H, Schmidt H, Vogt J, Gleichmann U (1992): Fibrinogen and Leucocyte Count as a Function of the Angiographic and Clinical Degree of Coronary Artery Disease. In: Fibrinogen: A “New”Cardiovascular Risk Factor. Ed.: Ernst, E., Koenig, W., Lowe, G.D.O., Meade, T.W. Blackwell-MZV Wien; 207–213 (

    Google Scholar 

  13. Braunwald E (1989): Unstable angina. A classification. Circulation 80: 410–414

    Article  PubMed  CAS  Google Scholar 

  14. Baller D, Sigmund-Duchanova H, Zipfel J, Heilige G (1979): Prediction of myocardial blood flow by DPTI and prediction of the adequacy of myocardial 02-supply by the DPTI/STTI ratio under maximal coronary dilatation. Basic Res. Cardiol 74; 378–388

    Article  PubMed  CAS  Google Scholar 

  15. Baller D, Bretschneider HJ, Hellige,G (1979): Validity of myocardial oxygen consumption parameters. Clin. Cardiol 2: 317–327

    PubMed  CAS  Google Scholar 

  16. Baller D, Schenk H, Strauer BE, Hellige G (1980): Myocardial oxygen consumption indices in man. Clin. Cardiol 3: 116–122

    Article  PubMed  CAS  Google Scholar 

  17. Baller D, Wolpers HG, Hoeft H, Korb H, Rösick A, Hellige G, Bretschneider HJ (1984): Increase of myocardial oxygen consumption due to active diastolic wall tension. Basic Res. Cardiol 76: 176–185

    Article  Google Scholar 

  18. Baller D, Wolpers HG, Zipfel J, Bretschneider HJ, Hellige G (1988): Comparison of the Effects of Right Atrial, Right Ventricular Apex and Atrioventricular Sequential Pacing on Myocardial Oxygen Consumption and Cardiac Efficiency PACE. 11: 394–403

    CAS  Google Scholar 

  19. Strauer BE, Vatah-Moghadam A, Kment A, Samtleben W, Volger E (1981): Use of plasmapheresis and immunosuppressive therapy in coronary microangiopathies. Bibl. Haematol 47: 213–227

    PubMed  Google Scholar 

  20. Ernst E, Matrai A, Schmolzl C, Magyarosy I (1987): Dose-effect relationship between smoking and blood rheology. Br. J. Haematol. 65: 485–487

    Article  PubMed  CAS  Google Scholar 

  21. Kannel WB, D’Agostino RB, Belanger AJ (1990): Fibrinogen, cigarette smoking, and riskof cardiovascular disease: Insights from the Framingham experience. Am. Heart J. 120: 672–676

    Article  PubMed  CAS  Google Scholar 

  22. Cook NS, Ubben D (1990): Fibrinogen as a major risk factor in cardiovascular disease. Trends Pharmacol. Sci. 11: 444–451

    Article  PubMed  Google Scholar 

  23. Leschke M, Mecklenbeck W, Schöbel F, Strauer BE (1992): Long-Term Intermittent Urokinase Therapy in Patients with Angina pectoris Refractory to Therapy. In: Fibrinogen: A “New” Cardiovascular Risk Factor. Ed.: Ernst E, Koenig W, Lowe GDO, Meade TW Blackwell-MZV, 434–439

    Google Scholar 

Download references

Authors
  1. Detlev Baller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eckart Miche
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kardiologische Klinik, Germany

    Ulrich Gleichmann  & Hermann Mannebach  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt

About this chapter

Cite this chapter

Baller, D., Miche, E. (1993). Alte und Neue Risikofaktoren unter besonderer Berücksichtigung des Fibrinogens. In: Gleichmann, U., Mannebach, H. (eds) 20 Jahre Kardiologie 1973–1993. Steinkopff. https://doi.org/10.1007/978-3-642-85427-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85427-9_10

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-0977-1

  • Online ISBN: 978-3-642-85427-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation